Leerink Partners Starts Neurogene (NGNE) at Outperform
Tweet
Share
E-mailGet Alerts NGNE Hot Sheet
Price: $36.68 +1.49%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Leerink Partners analyst Mani Foroohar initiates coverage on Neurogene (NASDAQ: NGNE) with a Outperform rating and a price target of $46.00.
For an analyst ratings summary and ratings history on Neurogene click here. For more ratings news on Neurogene click here.
Shares of Neurogene closed at $29.96 yesterday.
You May Also Be Interested In
- Neurogene (NGNE) PT Lowered to $65 at H.C. Wainwright
- Chardan Starts Odysight.AI Inc. (ODYS) at Buy
- Goldman Sachs Resumes Luxshare Precision (002475:CH) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
